共 50 条
[46]
A modified treat-and-extend regimen of aflibercept for treatment-naïve patients with neovascular age-related macular degeneration
[J].
Graefe's Archive for Clinical and Experimental Ophthalmology,
2017, 255
:657-664
[47]
EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION
[J].
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES,
2018, 38 (09)
:1795-1800
[49]
Intravitreal Aflibercept (Eylea®): A Review of Its Use in Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion
[J].
Drugs & Aging,
2014, 31
:395-404
[50]
Outcomes of switching treatment to aflibercept in patients with macular oedema secondary to central retinal vein occlusion refractory to ranibizumab
[J].
International Ophthalmology,
2018, 38
:207-213